DAWN
Price
$12.67
Change
-$0.02 (-0.16%)
Updated
Dec 24, 02:00 PM (EDT)
76 days until earnings call
DNLI
Price
$20.92
Change
+$0.14 (+0.67%)
Updated
Dec 24, 02:00 PM (EDT)
69 days until earnings call
Ad is loading...

DAWN vs DNLI

Header iconDAWN vs DNLI Comparison
Open Charts DAWN vs DNLIBanner chart's image
Day One Biopharmaceuticals
Price$12.67
Change-$0.02 (-0.16%)
Volume$26.8K
CapitalizationN/A
Denali Therapeutics
Price$20.92
Change+$0.14 (+0.67%)
Volume$62.46K
CapitalizationN/A
DAWN vs DNLI Comparison Chart
Loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DAWN vs. DNLI commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a Hold and DNLI is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (DAWN: $12.69 vs. DNLI: $20.78)
Brand notoriety: DAWN and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 62% vs. DNLI: 103%
Market capitalization -- DAWN: $1.28B vs. DNLI: $3.01B
DAWN [@Biotechnology] is valued at $1.28B. DNLI’s [@Biotechnology] market capitalization is $3.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 0 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • DAWN’s FA Score: 0 green, 5 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, DAWN is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 4 TA indicator(s) are bullish while DNLI’s TA Score has 4 bullish TA indicator(s).

  • DAWN’s TA Score: 4 bullish, 4 bearish.
  • DNLI’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DAWN is a better buy in the short-term than DNLI.

Price Growth

DAWN (@Biotechnology) experienced а +0.55% price change this week, while DNLI (@Biotechnology) price change was -10.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.99%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +3.17%.

Reported Earning Dates

DAWN is expected to report earnings on Mar 10, 2025.

DNLI is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-0.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($3.01B) has a higher market cap than DAWN($1.28B). DNLI YTD gains are higher at: -3.169 vs. DAWN (-13.082). DAWN has higher annual earnings (EBITDA): -210.08M vs. DNLI (-496.05M). DNLI has more cash in the bank: 837M vs. DAWN (558M). DAWN has less debt than DNLI: DAWN (2.62M) vs DNLI (52.5M). DAWN has higher revenues than DNLI: DAWN (102M) vs DNLI (0).
DAWNDNLIDAWN / DNLI
Capitalization1.28B3.01B42%
EBITDA-210.08M-496.05M42%
Gain YTD-13.082-3.169413%
P/E RatioN/AN/A-
Revenue102M0-
Total Cash558M837M67%
Total Debt2.62M52.5M5%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNDNLI
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 26 days ago
84%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGWRX52.610.56
+1.08%
American Century Growth R
BFONX21.980.12
+0.55%
Biondo Focus Investor
EQTKX16.620.09
+0.54%
Shelton Equity Income Class K
CSRYX35.640.16
+0.45%
Columbia Select Large Cap Value Inst3
CRCRX9.720.03
+0.31%
NYLI CBRE Real Estate Class C